Environmental surveillance and other control measures in the prevention of nosocomial fungal infections

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 2, 2001, Pages 38-45

  Caillot, D ^a   Mannone, L ^a   Cuisenier, B ^a   Couaillier, J F ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT CYTOKINE;

AIR QUALITY CONTROL; ANIMAL CELL; CANDIDA; CONTROLLED STUDY; CROSS INFECTION; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENVIRONMENTAL MONITORING; FUNGAL CELL CULTURE; FUNGUS TRANSMISSION; HIGH RISK PATIENT; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION RISK; MYCOSIS; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANIMALIA; ASPERGILLUS; CANDIDA; FUNGI;

EID: 0035746973     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2001.tb00008.x     Document Type: Review

References (58)

1. The epidemiology and prevention of invasive aspergillosis
2. Epidemiology of nosocomial fungal infections: Invasive aspergillosis and the environment
3. Invasive aspergillosis
4. Aspergillus fumigatus and aspergillosis
5. Epidemiology of nosocomial fungal infections
6. Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: Nosocomial acquisition in a laminar-air flow room
7. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
8. An outbreak of aspergillosis in a general ITU
9. Preventing postoperative burn wound aspergillosis
10. Invasive Aspergillus spp. infection in rheumatology patients
11. Invasive pulmonary aspergillosis in a critically ill neonate: Case report and review of invasive aspergillosis during the first 3 months of life
12. Nosocomial outbreak of Aspergillus fumigatus infection among patients in a renal unit?
13. The prevention of invasive aspergillosis - A realistic goal?
14. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-90 National Nosocomial Infections Surveillance System
15. Major trends in the microbial etiology of nosocomial infection
16. Emerging fungal pathogens
17. Hospital-acquired wound mucormycosis
18. Fungal endophthalmitis following intraocular lens implantation: A surgical epidemic
19. Candida and Malassezia as nursery pathogens
20. Trichosporonosis in patients with neoplastic disease
21. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit
22. Contaminated skin lotion: The source of an outbreak of Paecilomyces lilacinus infections at a BMT unit
23. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor
24. Catheter-related fungemia by Hansenula anomala
25. Guideline for Prevention of Nosocomial Pneumonia
26. Fungal surveillance of an open haematology ward
27. Air cultures for fungi. Epidemiology and Infection Control Microbiology
28. Value of environmental sampling and molecular typing of aspergilli to assess nosocomial sources of aspergillosis
29. Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus
30. Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus
31. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings
32. Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients
33. Molecular epidemiology of nosocomial invasive aspergillosis
34. Hospital epidemiologic surveillance for invasive aspergillosis: Patient demographics and the utility of antigen detection
35. Water as a source of filamentous fungi in a childhood bone marrow transplantation unit
36. Kitchens as a source of Aspergillus niger infection
37. Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients
38. Which bone marrow transplant recipients are at risk of acquiring life-threatening fungal infections?
39. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
40. The isolation of Aspergillus fumigatus after heart transplantation is highly predictive of invasive aspergillosis
41. Invasive aspergillosis in transplant recipients
42. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use
43. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: A retrospective study
44. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results of a three-year prospective study
45. The EPCAN Project Group. Risk factors for invasive candidiasis in non-neutropenic critically ill patients
46. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
47. Candidiasis in an intensive care unit
48. The pattern of fungal infections in critically ill surgical patients
49. Fungal sepsis: Multisite colonization versus fungemia
50. Candida colonization and subsequent infections in critically ill surgical patients
51. Preventing intra-abdominal candidiasis in surgical patients
52. International conference for the development of a consensus on the management and prevention of severe candidal infections
53. Clinical presentation of fungal infections in a hospital
54. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
55. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis